Ignite Creation Date:
2025-12-24 @ 12:04 PM
Ignite Modification Date:
2025-12-27 @ 10:42 PM
Study NCT ID:
NCT05406661
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-10-19
First Post:
2022-06-01
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Registry of Local Recurrences After Breast-conserving Surgery
Sponsor:
Universidade do Porto
Organization:
Study Overview
Official Title:
Registry of Local Recurrences After Breast-conserving Surgery in Portugal and Spain
Status:
NOT_YET_RECRUITING
Status Verified Date:
2023-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
R_ReLoCC
Brief Summary:
The ReLoCC project is a prospective, multicenter, clinical study to register cases of local recurrence after breast-conserving surgery, in centers dedicated to the treatment of breast cancer, in Portugal and Spain.
The comparison of the results obtained will allow the optimization of the treatment, making it increasingly personalized.
The comparison of the results obtained will allow the optimization of the treatment, making it increasingly personalized.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: